Immune Response Following Seasonal Influenza Vaccination

NCT03163342 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Altimmune, Inc.

Collaborators